Intra-Cellular Therapies Inc. buy TD Cowen
Start price
11.12.23
/
50%
€55.30
Target price
11.12.24
€69.65
Performance (%)
20.25%
Price
27.08.24
€66.50
Summary
This prediction is currently active. The prediction currently has a performance of 20.25%. This prediction currently runs until 11.12.24. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | -2.920% | -2.920% |
iShares Core DAX® | 1.937% | 1.473% |
iShares Nasdaq 100 | -1.186% | -0.040% |
iShares Nikkei 225® | 1.938% | 4.205% |
iShares S&P 500 | -0.023% | 0.109% |
Comments by TD_Cowen for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at TD Cowen. They set an "outperform" rating and a $75.00 price target on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by TD_Cowen for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.50
18.04.24
18.04.24
€84.35
18.04.25
18.04.25
-2.92%
27.08.24
27.08.24